A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

Clinical trial NCT01894958 · COMPLETED

Trial details

NCT number: NCT01894958
Sponsor: Neuren Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2014-01-01
Primary completion: 2015-09-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.